Nearly 12 months later, green shoots may finally be appearing following a desperately dark time for the German group that invented aspirin. Bayer announced plans earlier this year to secure €2 ...

The German pharmaceutical and agricultural conglomerate said the Federal Court of Australia closed the last pending case in ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

The Bayer Group has announced its full-year financial results for 2012, which turned out to be very successful for all subgroups. As a whole, sales for the Group grew by 8.8% to €39,760 million ...

“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

Since becoming Bayer's CEO, Bill Anderson has introduced striking changes to the company, including an overhaul of its budget system, which he sees as the driving source of corporate bureaucracy.

Teams do not pay a fee for placement on Forbes Top Advisor rankings, which are independently determined by Shook Research. Source: Forbes.com (Awarded Jan 2025) Data Compiled By Shook Research LLC ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Last year, Bayer launched a project to explore the use ... see if AI can be used to reduce or remove the need for a control group in some clinical trials, for example in rare diseases where ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Trendlines Group Ltd. has announced the dissolution of the Bayer Trendlines Agtech Fund, originally set to ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment expected to launch as early as ...